The ThinPrep® Pap Test is the only liquid-based cytology method approved by the U.S. Food and Drug Administration (FDA) as "significantly more effective" than the conventional Pap smear for detection of cervical abnormalities. Even more importantly, the ThinPrep Pap Test is currently the only liquid-based cytology method approved by the FDA for human papillomavirus (HPV), Chlamydia and Gonorrhea (CT/NG) testing, and is the most widely used method for cervical cancer screening in the United States.

While the conventional Pap smear has long been a fixture of preventive healthcare and has saved countless lives that may otherwise have been lost to cervical cancer, Cytyc's ThinPrep Pap Test is significantly more effective in detecting the precursors to cervical cancer than the conventional Pap smear.

The ThinPrep System improves the quality of the sample by preparing a slide that is more suitable for the diagnostic review process. Because a ThinPrep Pap Test slide is easier to read, it can help to increase the level of review accuracy for either a manual or computer-aided imaging review that assesses and identifies abnormal cells.